dihexa peptide benefits human clinical trial trials status Dihexa shows neurotrophic activity exceeding BDNF in preclinical studies DIHEXA | Synthetic DIHEXA is changing the conversation

Seiwerth and colleagues (2021) published a comprehensive review in Frontiers in Pharmacology documenting BPC-157s effects across 22 separate gastrointestinal injury models, including perforated bowel, anastomosis healing, short bowel syndrome, and stress-induced ulceration

I love it Love this shot

Neuroprotection Early research suggests BPC-157 supports nerve repair and protection

Over 35 clinical studies back this patented form of NR that showed it's safe and works well to raise NAD+ levels [27]

CHOP, C/EBP homologous protein

These ranges are research planning, not personal dosing recommendations, and no published human Phase 2 or Phase 3 dose-finding trial exists